Menu
ÚHKT

Impaktované publikace

[21]

Anděl, M.; Kléma, J.; Krejčík, Z.

Network-constrained forest for regularized classification of omics data

[rok vydání 2015, impact factor 3.503 ]

[22]

Šestáková, Š.; Krejčík, Z.; Folta, A.; Cerovská, E.; Šálek, C.; Dostálová Merkerová, M.; Pecherková, P.; Ráčil, Z.; Mayer, J.; Cetkovský, P.; Remešová, H.

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations

[rok vydání 2019, impact factor 3.436 ]

[23]

Parikova, A.; Hruba, P.; Krejcik, Z.; Stranecky, V.; Franekova, J.; Krediet, R.T.; Viklicky, O.

Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes

[rok vydání 2020, impact factor 3.377 ]

[24]

Krejcik, Z.; Belickova, M.; Hrustincova, A.; Votavova, H.; Jonasova, A.; Cermak, J.; Dyr, J.E.; Merkerova, M.D.

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia

[rok vydání 2018, impact factor 2.859 ]

[25]

Bystricka, D.; Sarova, I.; Zemanova, Z.; Brezinova, J.; Lizcova, L.; Izakova, S.; Dostalova-Merkerova, M.; Krejcik, Z.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cerna, O.; Cermak, J.; Michalova, K.

Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites

[rok vydání 2011, impact factor 2.764 ]

[26]

Zemanova, Z.; Michalova, K.; Buryova, H.; Brezinova, J.; Kostylkova, K.; Bystricka, D.; Novakova, M.; Sarova, I.; Izakova, S.; Lizcova, L.; Ransdorfova, S.; Krejcik, Z.; Dostalova Merkerova, M.; Dohnalova, A.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cermak, J.

Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis

[rok vydání 2014, impact factor 2.692 ]

[27]

Dostalova Merkerova, M.; Krejcik, Z.; Belickova, M.; Hrustincova, A.; Klema, J.; Stara, E.; Zemanova, Z.; Michalova, K.; Cermak, J.; Jonasova, A.

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide

[rok vydání 2014, impact factor 2.544 ]

[28]

Votavova, H.; Merkerova, M.D.; Krejcik, Z.; Fejglova, K.; Vasikova, A.; Pastorkova, A.; Tabashidze, N.; Topinka, J.; Balascak, I.; Sram, R.J.; Brdicka, R.

Deregulation of gene expression induced by environmental tobacco smoke exposure in pregnancy

[rok vydání 2012, impact factor 2.477 ]

[29]

Krejčík, Z.; Beličková, M.; Hruštincová, A.; Kléma, J.; Zemanová, Z.; Michalová, K.; Čermák, J.; Jonášová, A.; Dostálová Merkerová, M.

Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment

[rok vydání 2015, impact factor 2.333 ]

[30]

Dostalova Merkerova, M.; Hrustincova, A.; Krejcik, Z.; Votavova, H.; Ratajova, E.; Cermak, J.; Belickova, M.

Microarray profiling defines circulating microRNAs associated with myelodysplastic syndromes

[rok vydání 2017, impact factor 1.696 ]

[31]

Belickova, M.; Cermak, J.; Dostalova Merkerova, M.; Vesela, J.; Krejcik, Z.; Cechova, E.; Zemanova, Z.; Michalova, K.; Votavova, H.; Caniga, M.; Neuwirtova, R.; Jonasova, A.

Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q)

[rok vydání 2012, impact factor 1.667 ]

[32]

Parikova, A.; Hruba, P.; Krediet, R.T.; Krejcik, Z.; et al.

Long-term peritoneal dialysis treatment provokes activation of genes related to adaptive immunity

[rok vydání 2020, impact factor 1.655 ]

[33]

Lhotska, H.; Zemanova, Z.; Cechova, H.; Ransdorfova, S.; Svobodova, K.; Kramar, F.; Krejcik, Z.; Michalova, K.

Primary and recurrent diffuse astrocytomas: genomic profile comparison reveals acquisition of biologically relevant aberrations

[rok vydání 2016, impact factor 1.455 ]